Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome
Top Cited Papers
- 1 December 2001
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 111 (8) , 607-613
- https://doi.org/10.1016/s0002-9343(01)00948-2
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine, 2000
- Effects of Cigarette Smoking, Diabetes, High Cholesterol, and Hypertension on All-Cause Mortality and Cardiovascular Disease Mortality in Mexican Americans: The San Antonio Heart StudyAmerican Journal of Epidemiology, 1996
- Dyslipidaemia is associated with insulin resistance in women with polycystic ovariesClinical Endocrinology, 1996
- Coronary Heart Disease Risk Factors in Women With Polycystic Ovary SyndromeArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Effects of Alcohol Consumption on Lipoproteins of Premenopausal WomenArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variablesClinical Endocrinology, 1994
- Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndromeClinical Endocrinology, 1992
- Serum cholesterol levels in a multiracial sample of 7,439 preschool children from ArizonaPreventive Medicine, 1992
- THE INDEPENDENT EFFECTS OF HYPERANDROGENAEMIA, HYPERINSULINAEMIA, AND OBESITY ON LIPID AND LIPOPROTEIN PROFILES IN WOMEN*Clinical Endocrinology, 1990
- High density lipoprotein cholesterol and mortality. The Framingham Heart Study.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988